Percutaneous Tricuspid Valve Replacement for a Stenosed Bioprosthesis

Percutaneous replacement of the aortic and pulmonic valves has rapidly gained acceptance in clinical practice as a feasible alternative to open valve surgery in patients deemed to be at high operative risk.1,2 Total percutaneous tricuspid valve replacement (TVR), on the other hand, has not yet been documented in humans, although this approach has been described in experimental animals.3 Webb et al4 have recently reported 1 case of TVR, using a valve designed for percutaneous use but inserted through a thoracotomy with direct puncture of the right atrium.We describe a …